OncoTargets and Therapy · 2015 · 19 citations · 64 references
MedicineOncologyPharmacologyChemotherapyMolecular OncologyTumor ProgressionCancer Cell SignalingCancer ProgressionCancer Stem Cell BiologyCancer Stem Cell MaintenanceCancer Stem CellsMetastatic Breast CancerBreast Cancer ChemotherapyCancer Stem Cell - Mediated ResistanceCancer Stem Cell TraitsCell Proliferation IndicesDifferentiation InhibitionTherapy-resistant Cancer Stem CellsTumor Suppressor LossTumor Suppressor P53
BACKGROUND: Breast cancer stem cells (BCSCs) are considered the cause of tumor growth, multidrug resistance, metastasis, and recurrence. Therefore, differentiation therapy to reduce self-renewal of BCSCs is a promising approach. We have examined the effects of 5-aza-2'-deoxycytidine (DAC) on BCSC differentiation. MATERIALS AND METHODS: BCSCs were treated with a range of DAC concentrations from 0.625 to 100 µM. The differentiation status of DAC-treated BCSCs was graded by changes in cell proliferation, CD44(+)CD24(-) phenotype, expression of tumor suppressor genes, including BRCA1, BRCA2, p15, p16, p53, and PTEN, and antitumor drug resistance. RESULTS: DAC treatment caused significant BCSC differentiation. BCSCs showed a 15%-23% reduction in proliferation capacity, 3.0%-21.3% decrease in the expression of BCSC marker CD44(+)/CD24(-), activation of p53 expression, and increased p15, p16, BRCA1, and BRCA2 expression. Concentrations of DAC ranging from 0.625 to 40 µM efficiently induce cell cycle arrest in S-phase. ABCG2, highly expressed in BCSCs, also decreased with DAC exposure. Of particular note, drug-sensitivity of BCSCs to doxorubicin, verapamil, and tamoxifen also increased 1.5-, 2.0-, and 3.7-fold, respectively, after pretreatment with DAC. CONCLUSION: DAC reduced breast cancer cell survival and induced differentiation through reexpression of tumor suppressor genes. These results indicate the potential of DAC in targeting specific chemotherapy-resistant cells within a tumor.
64
Prospective identification of tumorigenic breast cancer cells
Muhammad Al‐Hajj, Max S. Wicha, Adalberto Benito‐Hernández et al. · Proceedings of the National Academy of Sciences · 2003 · 10.4K citations · Full text
Medicine, Cell Biology, Oncology +11
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Gregory J. Hannon, David Beach · Nature · 1994 · 1.9K citations
let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
Fengyan Yu, Herui Yao, Pengcheng Zhu et al. · Cell · 2007 · 1.9K citations · Full text